pharmaphorum

MARCH 21, 2022

Although resources exist for digital health entrepreneurs looking to raise their first key investment round, industry advice on next steps is harder to find. The growth of a start-up after obtaining Series A funding is a transformational phase when scaling up the company becomes critical. The CEO can experience pressure to deliver on the revenue growth goals, whilst still developing their product, growing the team, and implementing core processes for the company.

Hospitals 145

Hospitals Pharmaceutical Companies Pharmaceutical Companies 145

Find Your Script

MARCH 21, 2022

Studying is a skill…one that we may or may not have mastered during many years of education. I know I went through different study methods before settling on one that worked for me during 7 years of higher education. An important part of successful studying is staying focused. If you also want to improve study habits, see this post on the topic.

130

130

Outsourcing Pharma

MARCH 22, 2022

The agency has approved Lynparza for use in the US as an adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer.

FDA 98

FDA 98

Pharma Marketing Network

MARCH 25, 2022

Members of a multidisciplinary care team may include physicians, nurses, pharmacists, radiologists, dieticians…the list goes on. But one key member is often omitted: the patient’s caregiver. With an estimated 65 million people serving as caregivers, 1 the role is now a factor in an ever-increasing list of healthcare priorities. Although the caregiver is seen as an extension of the patient and their role is not strictly defined, they are informal members of the front-line care team.

Labelling 98

Labelling FDA 98

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

MARCH 22, 2022

Virtual and augmented reality tools have reached a level of maturity to be utilised across various industries. In this article, Ben Hargreaves asks whether there is particular potential for the technologies to revolutionise staff training and reduce costs in pharma manufacturing. Virtual reality (VR) and augmented reality (AR) have spent a lot of time in the headlines recently.

Pharmaceutical Companies 137

Pharmaceutical Companies Pharmaceutical Companies 137

Pharma Times

MARCH 24, 2022

The platform to build a digital-ready frontline workforce will be available to all NHS and social care staff

63

63

Roots Analysis

MARCH 24, 2022

Scientific fields involved in high throughput measurement of biological molecules are referred with the suffix- omics including, transcriptomics, genomics, proteomics and metabolomics. Genomics is the study of genetic material within a cell, and transcriptomics is the study of gene activity in different cells. Likewise, metabolomics refers to the study of byproducts of metabolism.

Compounding 52

Compounding 52

pharmaphorum

MARCH 23, 2022

Four out of five biopharma companies think that the market opportunity for connected health products exceeds their traditional drug business, but adoption remains low, with only 20% of use cases at present going beyond proof of concept. That’s one of the conclusions of a new study by Capgemini, which suggests that the number of approved connected health offerings – digital health products and services including wearables, digital therapeutics and software-as-a-medical-device (SaMD) – will

124

124

Pharma Times

MARCH 21, 2022

Patients eligible to receive Takeda’s Exkivity (mobocertinib) have a rare form of lung cancer that cannot be removed by surgery

56

56

Outsourcing Pharma

MARCH 25, 2022

The Pancreatic Cancer Action Network has engaged five new clinical trial sites in the US, which will aid in evaluation of Novartisâ investigational therapy.

91

91

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmD Live

MARCH 23, 2022

If you’ve implemented chronic care management (CCM) or remote physiologic monitoring (RPM, a.k.a. remote patient monitoring) in your practice, you know that they generate new streams of revenue while allocating more time to take better care of your patients—with potentially life-saving results. In fact, Medicare is so confident that these programs will pay off that it has dramatically increased CCM overall reimbursement rates for 2022.

52

52

pharmaphorum

MARCH 25, 2022

Tech giant Google has filed for FDA approval to use its Fitbit wearable to help detect atrial fibrillation (AFib), a common heart abnormality that raises the risk of heart attack, stroke and sudden death. Fitbit is already approved by the FDA to provide electrocardiogram (ECG) monitoring of heart rhythms, and in 2020 its Sense Smartwatch was cleared by the regulator to use the ECG functionality to detect AFib – although that requires active input from the user.

FDA 122

FDA 122

Pharma Times

MARCH 24, 2022

Collaboration will focus on AI analysis of flu progression, immune responses and the development of new vaccines

Immunization 52

Immunization Vaccines 52

Outsourcing Pharma

MARCH 24, 2022

The companyâs analysis of clinical research activity in the region shows the conflict will have long-lasting effects that reach beyond the countryâs borders.

59

59

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Marketing Network

MARCH 23, 2022

REGISTER HERE. Join PMN and industry marketing experts on April 28th at 12PM EST , to learn more about how to elevate your patient engagement marketing. Panels include: Effective Use of Data in DTC Marketing. There is no question that data is the path to better understanding your audience, but what data points are most important? What’s useful, and what’s misleading?

52

52

pharmaphorum

MARCH 25, 2022

In January, PLOS Digital Health published a study which claimed that there’s “sparse” data to support the efficacy of most mental health apps. In their meta-analysis of published studies, the authors found universal deficiencies and concluded that there’s no convincing evidence that app-based interventions deliver meaningful outcomes. Without digging further, one might think the current case for digital therapeutics is weak.

FDA 115

FDA 115

Pharma Mirror

MARCH 22, 2022

SmiLe Incubator’s angel investment company, SmiLe Inject Capital, invests 2 MSEK in Call Knut, an incubator company that is developing a voice robot- based service using AI and ordinary phone calls as a complement in communicating with and caring for elderly people living on their own. The investment will be used to complete the development of the product and enable a commercial launch during the year.

Communication 52

Communication 52

Outsourcing Pharma

MARCH 22, 2022

The pharmaceutical company has agreed to provide its Paxlovid oral COVID-19 treatment to the global charity, covering 95 low- and middle-income countries.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Roots Analysis

MARCH 21, 2022

Over the years, the incidence and prevalence of chronic diseases, have increased significantly. Presently, the recommended treatment options for such clinical conditions are mostly biologics, which need to be administered via parenteral routes to ensure maximum therapeutic benefit. Given the inherent requirement for frequent medication, patients suffering from such long-lasting clinical conditions generally end up spending high amounts on the prescribed therapeutic regimen, and numerous hospital

Hospitals 52

Hospitals Vaccines 52

pharmaphorum

MARCH 24, 2022

Ann Aerts, head of the Novartis Foundation, tells us about AI4Leprosy, a diagnostic assistant researchers developed that helps healthcare workers detect leprosy with over 90% accuracy using pictures of a patient’s skin lesion. . Leprosy has existed for more than 3,000 years and is the one of the oldest diseases known to humanity. Though a cure is available, 200,000 individuals are still diagnosed with the disease each year. “We’ve managed to reduce the burden of leprosy by 95%

111

111

Pharma Mirror

MARCH 22, 2022

PRINCETON, N.J. and CHICAGO. Indegene, a technology-led global healthcare solutions provider, and metaMe Health, Inc. (metaMe), a Prescription Digital Therapeutics (PDT) company and developer of Regulora®, today announced a partnership to bring Regulora to market for the treatment of abdominal pain due to Irritable Bowel Syndrome (IBS). IBS is a chronic condition that affects 10-15% of adults in the United States.

FDA 52

FDA 52

Pharma Times

MARCH 25, 2022

The site in Kent will support the manufacture of regulatory approved cannabis-based medicines while also leveraging environmental practices

47

47

Med Ed 101

MARCH 23, 2022

As a geriatric pharmacist, I understand how difficult it can be to manage polypharmacy and pain management. I had the honor of being invited onto the Pain Pod. This podcast is put together by Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS. We addressed many different aspects of polypharmacy and pain management in our 40+ minute […]. The post Polypharmacy and Pain Management – Podcast Special!

40

40

pharmaphorum

MARCH 23, 2022

Whether you’re a large pharma company or a small, emerging one, communication is key. Success or failure hinges on communicating the advantages of your offerings to both prescribing providers and patients. Join us on Tuesday 12 th April at 13:00 BST / 14:00 CET / 8:00 am EDT as panelists lay out how a better approach to communication can lead to improved patient outcomes, preventing drop-off rates, better predicting product forecasts, increasing script volume, integrating localised digital strat

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies 105

Pharma Marketing Network

MARCH 20, 2022

Reuter’s Pharma USA 2022 was truly awesome. It feels great to finally get back “in person” and see people again. There was a strong showing of clients and a full agenda of great presentations. One of the overall themes that emerged based on the numerous case studies, examples, and presentations is that pharma has not been sitting still during COVID.

FDA 40

FDA 40

Pharma Times

MARCH 25, 2022

STP1 has demonstrated good safety and tolerability profiles, while also showing positive results for neurological function

45

45

Med Ed 101

MARCH 20, 2022

Pharmacist reimbursement has been a frustrating battle for us pharmacists. We don’t get enough respect when it comes to legislation (i.e. provider status) and reimbursement of clinical services. There was a recent research article put out by the CDC that demonstrates the challenges that pharmacists face with regards to doing the right thing for patients […].

40

40

pharmaphorum

MARCH 24, 2022

GlaxoSmithKline has thrown its financial and drug development weight behind LifeMine Therapeutics, a US startup that aims to find new therapeutics from fungi – widely regarded as an underexplored resource of biologically-active compounds. There’s a rich history of finding useful medicines from fungi, from the antibiotic penicillin to immune suppressant cyclosporine and cholesterol drug lovastatin.

Compounding 105

Compounding Immunization 105

pharmaphorum

MARCH 25, 2022

The FDA has given ViiV healthcare and Johnson & Johnson a boost in the market for long-acting injectable HIV drugs, approving a new regimen for their Cabenuva product that does away with the need for an oral lead-in period. The label update means that people living with HIV who want to trade their daily oral doses of antiretroviral therapy (ART) for an injection delivered once a month or every two months will no long need to transition to oral therapy with the active ingredients in Cabenuva

FDA 98

FDA Labelling 98

pharmaphorum

MARCH 25, 2022

AstraZeneca’s hopes of developing its PD-L1 inhibitor Imfinzi for cervical cancer have been hit by a failed phase 3 trial of the drug alongside chemotherapy as a first-line treatment for women with locally-advanced tumours. The CALLA trial compared Imfinzi (durvalumab) with chemoradiotherapy (CRT) to CRT alone in an all-comer cervical cancer population – regardless of PD-L1 biomarker status – hoping to extend the use of immunotherapy in this type of cancer.

Chemotherapy 98

Chemotherapy 98

pharmaphorum

MARCH 23, 2022

It’s only been two weeks since Pfizer closed its $6.7 billion takeover of Arena Pharmaceuticals, and it already has the positive data it was hoping for with etrasimod, the main asset in the deal. In its first phase 3 readout, oral S1P receptor modulator etrasimod met its objectives in patients with moderately-to-severely active ulcerative colitis, who had previously failed or were intolerant to at least one prior conventional, biological or JAK inhibitor therapy.

98

98

pharmaphorum

MARCH 25, 2022

Jazz Pharma has started construction of a manufacturing facility in the UK that will be used to manufacture cannabinoid drugs from its recently acquired GW Pharma subsidiary. The 60,000 sq. ft. facility at Kent Science Park (KSP) in Sittingbourne is due to open in 2024, and when fully operational will create more than 100 new highly skilled jobs. It will be used to build capacity for Jazz’s two approved cannabinoid medicines – Sativex (nabiximols) and Epidiolex/Epidyolex (cannabidiol) – as

Chemotherapy 98

Chemotherapy 98

pharmaphorum

MARCH 23, 2022

Merck & Co’s chief medical officer and head of clinical development Dr Roy Baynes has announced his retirement from the company to take up a new role alongside his former colleague Roger Perlmutter at biotech Eikon Therapeutics. Baynes will bring a nine-year stint at Merck, known as MSD outside North America, to an end in July, when he will be replaced by Dr Eliav Barr, currently senior vice president of global clinical development.

Vaccines 98

Vaccines FDA 98